{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:04:11Z","timestamp":1784171051275,"version":"3.55.0"},"reference-count":50,"publisher":"Tsinghua University Press","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine whether biological age, estimated using phenotypic age (PhenoAge) and PhenoAge acceleration, predicts in-hospital and intermediate-term outcomes after acute myocardial infarction (AMI) in older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of 192 consecutive adults [median age: 71 (62\u201378) years] admitted with AMI to a national tertiary center in 2022. PhenoAge metrics were derived from routine admission laboratory parameters. Patients were followed until 30 August 2025. Outcomes included in-hospital mortality and two composite endpoints: (1) all-cause mortality, non-fatal myocardial infarction, or revascularization; and (2) the above plus hospitalization for heart failure. Logistic regression models and Cox proportional hazards regression models were adjusted for baseline cardiovascular comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>PhenoAge acceleration was independently associated with in-hospital mortality (OR = 1.051, 95% CI: 1.018\u20131.084, P = 0.002), whereas chronological age was not, and PhenoAge also demonstrated independent association (OR = 1.042, 95% CI: 1.013\u20131.072, P = 0.004). Over a median follow-up of 1285 days, all three aging metrics were independently associated with both composite endpoints and heart failure hospitalization in multivariable analyses. Receiver operating characteristic analyses demonstrated similar discriminative performance across metrics for intermediate-term outcomes [area under the curve (AUC) = 0.63\u20130.71]. PhenoAge demonstrated significant incremental value over chronological age [net reclassification improvement (NRI) = 0.38\u20130.43, integrated discrimination improvement (IDI) = 0.059\u20130.069, P \u2264 0.005].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>PhenoAge acceleration independently predicted in-hospital mortality following AMI, suggesting it captures acute physiological vulnerability not reflected by chronological age. Although PhenoAge acceleration showed comparable intermediate-term discriminatory performance to chronological age, PhenoAge demonstrated significant incremental prognostic value beyond chronological age. Biological aging assessment may help identify biologically vulnerable patients at presentation and support personalized risk stratification in geriatric cardiology. These findings support further prospective evaluation of biological aging metrics in older adults with acute coronary syndromes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.26599\/1671-5411.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:22:22Z","timestamp":1784168542000},"page":"355-363","source":"Crossref","is-referenced-by-count":0,"title":["Biological age acceleration predicts mortality and heart failure after acute myocardial infarction in older adults"],"prefix":"10.26599","volume":"23","author":[{"given":"Matthias","family":"Grech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Grech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Schembri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Fenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"C L\u00f3pez-Ot\u00edn. The hallmarks of aging. 2013, 153: 1194-1217.","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/joim.13533","article-title":"Epigenetic aging: biological age prediction and informing a mechanistic theory of aging","volume":"292","author":"A Li","year":"2022","unstructured":"A Li. Epigenetic aging: biological age prediction and informing a mechanistic theory of aging. 2022, 292: 733-744.","journal-title":"J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"S Horvath","year":"2013","unstructured":"S Horvath. DNA methylation age of human tissues and cell types. 2013, 14: R115.","journal-title":"Genome Biol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"G Hannum","year":"2013","unstructured":"G Hannum. Genome-wide methylation profiles reveal quantitative views of human aging rates. 2013, 49: 359-367.","journal-title":"Mol Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.18632\/aging.101508","article-title":"Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies","volume":"10","author":"S Horvath","year":"2018","unstructured":"S Horvath. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and\n                      ex vivo\n                      studies. 2018, 10: 1758-1775.","journal-title":"Aging (Albany NY)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18632\/aging.101684","article-title":"DNA methylation GrimAge strongly predicts lifespan and healthspan","volume":"11","author":"AT Lu","year":"2019","unstructured":"AT Lu. DNA methylation GrimAge strongly predicts lifespan and healthspan. 2019, 11: 303-327.","journal-title":"Aging (Albany NY)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13148-025-01872-6","article-title":"Associations between five indicators of epigenetic age acceleration and all-cause and cause-specific mortality among US adults aged 50 years and older","volume":"17","author":"Y Zou","year":"2025","unstructured":"Y Zou. Associations between five indicators of epigenetic age acceleration and all-cause and cause-specific mortality among US adults aged 50 years and older. 2025, 17: 66.","journal-title":"Clin Epigenetics"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1007\/s11357-025-01612-x","article-title":"Biological age construction for prediction of mortality in the Chinese population","volume":"47","author":"K Wang","year":"2025","unstructured":"K Wang. Biological age construction for prediction of mortality in the Chinese population. 2025, 47: 5869-5880.","journal-title":"Geroscience"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1093\/gerona\/glac147","article-title":"Inflammation and epigenetic aging are largely independent markers of biological aging and mortality","volume":"77","author":"L Cribb","year":"2022","unstructured":"L Cribb. Inflammation and epigenetic aging are largely independent markers of biological aging and mortality. 2022, 77: 2378-2386.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e1002718","DOI":"10.1371\/journal.pmed.1002718","article-title":"A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study","volume":"15","author":"Z Liu","year":"2018","unstructured":"Z Liu. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. 2018, 15: e1002718.","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e24321","DOI":"10.1002\/clc.24321","article-title":"Association between phenotypic age and the risk of mortality in patients with heart failure: a retrospective cohort study","volume":"47","author":"X Xu","year":"2024","unstructured":"X Xu. Association between phenotypic age and the risk of mortality in patients with heart failure: a retrospective cohort study. 2024, 47: e24321.","journal-title":"Clin Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"glae005","DOI":"10.1093\/gerona\/glae005","article-title":"Association of epigenetic age and everyday discrimination with longitudinal trajectories of chronic health conditions in older adults","volume":"79","author":"M Mutambudzi","year":"2024","unstructured":"M Mutambudzi. Association of epigenetic age and everyday discrimination with longitudinal trajectories of chronic health conditions in older adults. 2024, 79: glae005.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1002\/ehf2.14446","article-title":"Causality between heart failure and epigenetic age: a bidirectional Mendelian randomization study","volume":"10","author":"F Zhang","year":"2023","unstructured":"F Zhang. Causality between heart failure and epigenetic age: a bidirectional Mendelian randomization study. 2023, 10: 2903-2913.","journal-title":"ESC Heart Fail"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/postmj\/qgae093","article-title":"PhenoAge and PhenoAgeAccel in the context of dyslipidemia: association with stroke and potential as a new predictor in the US general population","volume":"101","author":"W Zhao","year":"2024","unstructured":"W Zhao. PhenoAge and PhenoAgeAccel in the context of dyslipidemia: association with stroke and potential as a new predictor in the US general population. 2024, 101: 17-28.","journal-title":"Postgrad Med J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e2215840120","DOI":"10.1073\/pnas.2215840120","article-title":"Epigenetic-based age acceleration in a representative sample of older Americans: associations with aging-related morbidity and mortality","volume":"120","author":"JD Faul","year":"2023","unstructured":"JD Faul. Epigenetic-based age acceleration in a representative sample of older Americans: associations with aging-related morbidity and mortality. 2023, 120: e2215840120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"RP91101","DOI":"10.7554\/eLife.91101","article-title":"Associations of combined phenotypic aging and genetic risk with incident cancer: a prospective cohort study","volume":"13","author":"L Bian","year":"2024","unstructured":"L Bian. Associations of combined phenotypic aging and genetic risk with incident cancer: a prospective cohort study. 2024, 13: RP91101.","journal-title":"Elife"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"17880","DOI":"10.1038\/s41598-025-00114-2","article-title":"Associations of biological aging with the morbidity and all-cause mortality of patients with lung cancer","volume":"15","author":"Q Xie","year":"2025","unstructured":"Q Xie. Associations of biological aging with the morbidity and all-cause mortality of patients with lung cancer. 2025, 15: 17880.","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"L Ferrucci. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. 2018, 15: 505-522.","journal-title":"Nat Rev Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2019.11.062","article-title":"Biological versus chronological aging: JACC Focus Seminar","volume":"75","author":"MR Hamczyk","year":"2020","unstructured":"MR Hamczyk. Biological versus chronological aging: JACC Focus Seminar. 2020, 75: 919-930.","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/gerona\/glw240","article-title":"Chronic inflammation: accelerator of biological aging","volume":"72","author":"B Foug\u00e8re","year":"2017","unstructured":"B Foug\u00e8re. Chronic inflammation: accelerator of biological aging. 2017, 72: 1218-1225.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","author":"ME Levine","year":"2018","unstructured":"ME Levine. An epigenetic biomarker of aging for lifespan and healthspan. 2018, 10: 573-591.","journal-title":"Aging (Albany NY)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4524032","DOI":"10.1155\/2022\/4524032","article-title":"Association between phenotypic age and mortality in patients with multivessel coronary artery disease","volume":"2022","author":"Q Ma","year":"2022","unstructured":"Q Ma. Association between phenotypic age and mortality in patients with multivessel coronary artery disease. 2022, 2022: 4524032.","journal-title":"Dis Markers"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"101670","DOI":"10.1016\/j.ijcha.2025.101670","article-title":"Association between phenotypic age and in-hospital outcomes in patients with acute myocardial infarction: a retrospective observational study","volume":"58","author":"Y Gao","year":"2025","unstructured":"Y Gao. Association between phenotypic age and in-hospital outcomes in patients with acute myocardial infarction: a retrospective observational study. 2025, 58: 101670.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-021-00646-9","article-title":"Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention","volume":"6","author":"X Zhu","year":"2021","unstructured":"X Zhu. Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. 2021, 6: 245.","journal-title":"Signal Transduct Target Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e1004343","DOI":"10.1371\/journal.pmed.1004343","article-title":"Health outcomes after myocardial infarction: a population study of 56 million people in England","volume":"21","author":"M Hall","year":"2024","unstructured":"M Hall. Health outcomes after myocardial infarction: a population study of 56 million people in England. 2024, 21: e1004343.","journal-title":"PLoS Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e018331","DOI":"10.1136\/bmjopen-2017-018331","article-title":"An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors","volume":"8","author":"JMIH Gho","year":"2018","unstructured":"JMIH Gho. An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors. 2018, 8: e018331.","journal-title":"BMJ Open"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1625239","DOI":"10.3389\/fcvm.2025.1625239","article-title":"The relationships between inflammatory biomarkers, plaque characteristics, and macrophage clusters in coronary plaque: a quantitative assessment of macrophages based on optical coherence tomography","volume":"12","author":"C Liu","year":"2025","unstructured":"C Liu. The relationships between inflammatory biomarkers, plaque characteristics, and macrophage clusters in coronary plaque: a quantitative assessment of macrophages based on optical coherence tomography. 2025, 12: 1625239.","journal-title":"Front Cardiovasc Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"132924","DOI":"10.1016\/j.ijcard.2024.132924","article-title":"High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patient with stable coronary disease: an optical coherence tomography study","volume":"421","author":"M Katamine","year":"2025","unstructured":"M Katamine. High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patient with stable coronary disease: an optical coherence tomography study. 2025, 421: 132924.","journal-title":"Int J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jcin.2025.01.440","article-title":"Relationships of hsCRP to high-risk vulnerable plaque after NSTEMI: insights from the PROSPECT II Trial","volume":"18","author":"O Fr\u00f6bert","year":"2025","unstructured":"O Fr\u00f6bert. Relationships of hsCRP to high-risk vulnerable plaque after NSTEMI: insights from the PROSPECT II Trial. 2025, 18: 1217-1228.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/nu15061517","article-title":"Anti-inflammatory effects of lipid-lowering drugs and supplements: a narrative review","volume":"15","author":"S Zivkovic","year":"2023","unstructured":"S Zivkovic. Anti-inflammatory effects of lipid-lowering drugs and supplements: a narrative review. 2023, 15: 1517.","journal-title":"Nutrients"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ekir.2024.02.1435","article-title":"Narrative review of immunomodulatory and anti-inflammatory effects of sodium-glucose cotransporter 2 inhibitors: unveiling novel therapeutic frontiers","volume":"9","author":"SA Lee","year":"2024","unstructured":"SA Lee. Narrative review of immunomodulatory and anti-inflammatory effects of sodium-glucose cotransporter 2 inhibitors: unveiling novel therapeutic frontiers. 2024, 9: 1601-1613.","journal-title":"Kidney Int Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/ijms26041670","article-title":"Anti-inflammatory effects of SGLT2 inhibitors: focus on macrophages","volume":"26","author":"EY Rykova","year":"2025","unstructured":"EY Rykova. Anti-inflammatory effects of SGLT2 inhibitors: focus on macrophages. 2025, 26: 1670.","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/01.CIR.0000027816.54430.96","article-title":"Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"106","author":"T Cyrus","year":"2002","unstructured":"T Cyrus. Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. 2002, 106: 1282-1287.","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.mayocp.2022.06.036","article-title":"Effect of the renin-angiotensin system inhibitors on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials","volume":"97","author":"K Awad","year":"2022","unstructured":"K Awad. Effect of the renin-angiotensin system inhibitors on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. 2022, 97: 1808-1823.","journal-title":"Mayo Clin Proc"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1148209","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"SF Mehdi","year":"2023","unstructured":"SF Mehdi. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. 2023, 14: 1148209.","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2468-2667(25)00163-X","article-title":"Burden of cardiovascular diseases in England (2020\u20132024): a national cohort using electronic health records data","volume":"10","author":"E Allara","year":"2025","unstructured":"E Allara. Burden of cardiovascular diseases in England (2020\u20132024): a national cohort using electronic health records data. 2025, 10: e943-e954.","journal-title":"Lancet Public Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.107.696906","article-title":"Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure","volume":"116","author":"SD Solomon","year":"2007","unstructured":"SD Solomon. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. 2007, 116: 1482-1487.","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejheart.2006.10.012","article-title":"Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM","volume":"9","author":"EF Lewis","year":"2007","unstructured":"EF Lewis. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. 2007, 9: 83-91.","journal-title":"Eur J Heart Fail"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"746494","DOI":"10.3389\/fphys.2021.746494","article-title":"Inflammation in human heart failure: major mediators and therapeutic targets","volume":"12","author":"M Reina-Couto","year":"2021","unstructured":"M Reina-Couto. Inflammation in human heart failure: major mediators and therapeutic targets. 2021, 12: 746494.","journal-title":"Front Physiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjcard.2022.08.013","article-title":"Frailty and hospitalization burden in patients with chronic heart failure","volume":"183","author":"A Mollar","year":"2022","unstructured":"A Mollar. Frailty and hospitalization burden in patients with chronic heart failure. 2022, 183: 48-54.","journal-title":"Am J Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"100602","DOI":"10.1016\/j.jnha.2025.100602","article-title":"Epigenetic clocks as mediators of health behaviors and mortality in middle-aged and older adults","volume":"29","author":"XL Chen","year":"2025","unstructured":"XL Chen. Epigenetic clocks as mediators of health behaviors and mortality in middle-aged and older adults. 2025, 29: 100602.","journal-title":"J Nutr Health Aging"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100271","DOI":"10.1016\/j.jnha.2024.100271","article-title":"Dietary diversity score and the acceleration of biological aging: a population-based study of 88, 039 participants","volume":"28","author":"Y Liu","year":"2024","unstructured":"Y Liu. Dietary diversity score and the acceleration of biological aging: a population-based study of 88, 039 participants. 2024, 28: 100271.","journal-title":"J Nutr Health Aging"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"100638","DOI":"10.1016\/j.jnha.2025.100638","article-title":"Differential associations of dietary inflammatory potential, antioxidant capacity, and Mediterranean diet adherence with biological aging: a UK Biobank study","volume":"29","author":"C Zhang","year":"2025","unstructured":"C Zhang. Differential associations of dietary inflammatory potential, antioxidant capacity, and Mediterranean diet adherence with biological aging: a UK Biobank study. 2025, 29: 100638.","journal-title":"J Nutr Health Aging"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e13873","DOI":"10.1002\/jcsm.13873","article-title":"Physical activity is associated with decreased epigenetic aging: findings from the Health and Retirement Study","volume":"16","author":"F Ammous","year":"2025","unstructured":"F Ammous. Physical activity is associated with decreased epigenetic aging: findings from the Health and Retirement Study. 2025, 16: e13873.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/gerona\/glz099","article-title":"A systematic review and meta-analysis of environmental, lifestyle, and health factors associated with DNA methylation age","volume":"75","author":"J Ryan","year":"2020","unstructured":"J Ryan. A systematic review and meta-analysis of environmental, lifestyle, and health factors associated with DNA methylation age. 2020, 75: 481-494.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"108109","DOI":"10.1016\/j.envint.2023.108109","article-title":"Associations between medium- and long-term exposure to air temperature and epigenetic age acceleration","volume":"178","author":"W Ni","year":"2023","unstructured":"W Ni. Associations between medium- and long-term exposure to air temperature and epigenetic age acceleration. 2023, 178: 108109.","journal-title":"Environ Int"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s12916-025-04410-6","article-title":"Long-term BMI trajectories and epigenetic age acceleration: the role of genetic risk for obesity","volume":"23","author":"Y Wen","year":"2025","unstructured":"Y Wen. Long-term BMI trajectories and epigenetic age acceleration: the role of genetic risk for obesity. 2025, 23: 589.","journal-title":"BMC Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"108616","DOI":"10.1016\/j.envint.2024.108616","article-title":"Associations of polycyclic aromatic hydrocarbons mixtures with cardiovascular diseases mortality and all-cause mortality and the mediation role of phenotypic ageing: a time-to-event analysis","volume":"186","author":"S Duan","year":"2024","unstructured":"S Duan. Associations of polycyclic aromatic hydrocarbons mixtures with cardiovascular diseases mortality and all-cause mortality and the mediation role of phenotypic ageing: a time-to-event analysis. 2024, 186: 108616.","journal-title":"Environ Int"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1186\/s12889-025-22374-3","article-title":"Associations of exposure to volatile organic compounds with biological aging: a cross-sectional study","volume":"25","author":"X Shi","year":"2025","unstructured":"X Shi. Associations of exposure to volatile organic compounds with biological aging: a cross-sectional study. 2025, 25: 1476.","journal-title":"BMC Public Health"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1504830","author":"","unstructured":"","journal-title":"null"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:22:23Z","timestamp":1784168543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2026.06.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2026.06.007","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}